Vaccine Doses

Quad supplies 79 million COVID-19 vaccine doses to Indo-Pacific nations

The Quad leaders, in joint statement, said due to the Quad Vaccine Partnership's financing of increased manufacturing capacity at the Hyderabad-based Biological E LTD, additional production in India will be on cards later this year

Long COVID: Double vaccination halves risk of developing lasting symptoms, shows study

The COVID Symptom Study's data shows that vaccines significantly reduce the risk of catching COVID-19, with only 0.2 percent of those fully vaccinated later testing positive for the virus

Ahead G7 Summit 2021, UNICEF, 100 heads of states and celebrities write open letter to G7 to donate vaccines

The UNICEF letter reminded the G7 nations the virus sees no borders and with the mutating strains, people will be safe only when everyone has access to vaccines.

Donating 20% of June-August vaccine stocks to COVAX, G7 and EU nations can close vaccine gap: UNICEF

Just 0.3 percent have been administered in the 29 lowest-income countries, home to nine percent of the world's population.

Over 84 lakh vaccines still available with states, UTs; 17.49 cr doses provided so far, says Centre

Out of the 53.25 lakh vaccine doses expected to be distributed among states and union territories in the next three days, Gujarat will get 8.98 lakh vaccine doses, the highest quota among all

Doubling time of COVID-19 cases in India falls from 504.4 days to 202.3 days, says health ministry

Ten states, including Maharashtra, Gujarat, Punjab, Delhi and Tamil Nadu, are showing an upward trajectory in the daily new COVID-19 cases, the ministry said

Will combining Oxford's vaccine with Russia's Sputnik V make it more effective?

It’s not yet known why reduced-dose of the Oxford vaccine showed better efficacy in trials, but it could be down to the viral vector.

COVID-19 vaccine to cost Rs 225 per dose in India says Serum Institute, will be made available to 92 nations

Serum Institute partners with Gavi and Bill & Melinda Gates Foundation to manufacture, deliver of up to 100 million doses of COVID-19 vaccines to India, other low and middle-income countries.

CanSino Biologics to begin final phase of human trials for its COVID-19 vaccine in Saudi Arabia

This final leg of human vaccine trials will recruit 5,000 volunteers above age 18 in Riyadh, Dammam and Mecca.